# Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury

> **NCT03069820** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 120 (estimated)

## Conditions studied

- Liver Injury, Drug-Induced

## Interventions

- **DRUG:** docetaxel and cisplatin

## Key facts

- **NCT ID:** NCT03069820
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-10
- **Primary completion:** 2018-01-01
- **Final completion:** 2018-01-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03069820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03069820, "Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03069820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*